Curious2018 – Future Insight is a new flagship healthcare conference launched this year by Merck to bring some of the greatest scientists and most accomplished entrepreneurs together on an invite-o
As the ASCO congress drew to a close, Johnson & Johnson filed for FDA approval of its BCMA-targeting CAR-T therapy Carvykti for use earlier in the treatment pathway fo
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas
